Delgocitinib, also known as Anzupgo, has been given the green light for NHS use for adults with moderate to severe chronic ...

A study has found that people with eczema are able to bathe either daily or weekly, without any impact on their symptoms.

The recommendation for delgocitinib, also known as Anzupgo and made by Leo Pharma, could also save the NHS millions of pounds ...

The cream can be used at home and is applied twice a day to the affected areas on the hands and wrists - it should be offered ...

More than 31 million people in the U.S. live with eczema, a chronic skin condition that can disrupt daily life yet continues ...

The National Institute for Health and Care Excellence (Nice) has recommended that the cream should be offered to people with ...

According to Nice, the rollout of delgocitinib could reduce outpatient procedures such as phototherapy, as well as freeing up ...

Chronic hand eczema is now considered a “common” skin disease in the United States, according to results from the CHECK study ...

A major study has found that people with eczema are able to bathe either daily or weekly, without any impact to their symptoms.The findings of the new ...

Speedskater Erin Jackson, who won a gold medal at the 2022 Beijing Winter Olympics, talks about how eczema has affected her, ...

From relentless itching and painful flare-ups to sleepless nights and emotional exhaustion, eczema can take a serious toll on ...

When most people think of eczema, they picture a dry, red, inflamed and itchy rash. But on darker skin tones, eczema can look ...